The provided peptide sequence corresponds to an internal region of the human LH beta subunit as well as an alpha subunit. This sequence analysis clarifies the assignment of certain residues in the alpha subunit and examines the nature of the amino-terminal heterogeneity found among different alpha subunits.
209A-1
LH Rabbit Polyclonal Antibody
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
UNSPSC-Code:
12352203
NACRES:
NA.41
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Empfohlene Produkte
Biologische Quelle
rabbit
Qualitätsniveau
100
500
Konjugat
unconjugated
Antikörperform
Ig fraction of antiserum
Antikörper-Produkttyp
primary antibodies
Klon
polyclonal
Beschreibung
For In Vitro Diagnostic Use in Select Regions (See Chart)
Form
buffered aqueous solution
Speziesreaktivität
human
Verpackung
vial of 0.1 mL concentrate (209A-14)
vial of 0.5 mL concentrate (209A-15)
bottle of 1.0 mL predilute (209A-17)
vial of 1.0 mL concentrate (209A-16)
bottle of 7.0 mL predilute (209A-18)
Hersteller/Markenname
Cell Marque®
Methode(n)
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100-1:500
Kontrolle
pituitary
Versandbedingung
wet ice
Lagertemp.
2-8°C
Visualisierung
cytoplasmic
Verwandte Kategorien
Allgemeine Beschreibung
Anti-LH is a useful marker in classification of pituitary tumors and the study of pituitary disease. It reacts with LH-producing cells (gonadotrophs).
Qualität
 IVD |  IVD |  IVD |  RUO |
Verlinkung
LH Positive Control Slides, Product No. 209S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
Physikalische Form
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
Angaben zur Herstellung
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
Sonstige Hinweise
For Technical Service please contact: 800-665-7284 or email: [email protected]
Rechtliche Hinweise
Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
Sie haben nicht das passende Produkt gefunden?
Probieren Sie unser Produkt-Auswahlhilfe. aus.
Hier finden Sie alle aktuellen Versionen:
Analysenzertifikate (COA)
Lot/Batch Number
Die passende Version wird nicht angezeigt?
Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
I Felix et al.
Human pathology, 22(7), 719-721 (1991-07-01)
A 19-year-old man with blurred vision, headache, and no signs or symptoms of hormone excess was found to have a pituitary adenoma. The tumor was removed by a transfrontal approach. He had postoperative radiation therapy, but subsequently had three recurrences
J J Kovalic et al.
Journal of neuro-oncology, 16(3), 227-232 (1993-06-01)
There is general agreement that postoperative radiation therapy is beneficial for patients with subtotally resected pituitary adenomas. We have identified 41 such patients treated during a 20-year period who received postoperative irradiation for a pituitary adenoma. The usual dose was
T Sano et al.
Virchows Archiv. A, Pathological anatomy and histopathology, 417(4), 361-367 (1990-01-01)
Two pituitary adenomas removed from a 37-year-old woman and a 26-year-old woman with typical Cushing's disease were studied by light and electron microscopy, immunohistochemistry and radioimmunoassay of tissue culture media. Both patients had high plasma levels of cortisol and normal
K Saccomanno et al.
The Journal of clinical endocrinology and metabolism, 78(5), 1103-1107 (1994-05-01)
Human nonfunctioning pituitary adenomas (NFPA) may produce CG in addition to the classical glycoprotein hormones (LH, FSH, and TSH). The aim of the present study was to localize LH beta, FSH beta, TSH beta, alpha-subunit (alpha SU), CG, and its
S La Rosa et al.
Virchows Archiv : an international journal of pathology, 437(3), 264-269 (2000-10-19)
Gonadotropin-releasing hormone (GnRH), which is a well-known regulator of gonadotroph function, has recently been considered to be a paracrine factor involved in the control of somatotroph, lactotroph, and corticotroph cells. GnRH action is initiated by binding to a specific cell
-
Is there any data related to the question below for the antibody LH_polyclonal?
1 answer-
Helpful?
-
Active Filters
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.
